Sanofi Agrees to R&D Partnership with Evotec

In an announcement via Genetic Engineering & Biotechnology News, “Evotec said yesterday it hammered out a definitive agreement for a five-year, minimum-guaranteed €250 million (nearly $270 million) strategic alliance with Sanofi focused on developing...

There is No Such Thing as “Low Hanging Fruit” in Drug R&D

Forbes just posted this thought-provoking article written by the former President of Pfizer Global Research.  Using an approach Merck attempted as an example, he discusses some of the challenges that decision makers face these days in relation to drug safety,...